Skip to main content
. 2022 Nov 1;379:e071380. doi: 10.1136/bmj-2022-071380

Fig 1.

Fig 1

Study flow diagram of patients starting sulfonylureas or glucagon-like peptide-1 receptor agonists (GPL-1 RAs) in UK Clinical Practice Research Datalink between 2007 and 2019. COPD=chronic obstructive pulmonary disease